newsfilter
← Latest News
GlobeNewswire·

CymaBay Therapeutics to Report First Quarter of 2023 Financial Results on Monday, May 15, 2023

NEWARK, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet